Cargando…
Cooperative inhibition of SNARE-mediated vesicle fusion by α-synuclein monomers and oligomers
The primary hallmark of Parkinson's disease (PD) is the generation of Lewy bodies of which major component is α-synuclein (α-Syn). Because of increasing evidence of the fundamental roles of α-Syn oligomers in disease progression, α-Syn oligomers have become potential targets for therapeutic int...
Autores principales: | Yoo, Gyeongji, Yeou, Sanghun, Son, Jung Bae, Shin, Yeon-Kyun, Lee, Nam Ki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155056/ https://www.ncbi.nlm.nih.gov/pubmed/34040104 http://dx.doi.org/10.1038/s41598-021-90503-0 |
Ejemplares similares
-
α-Synuclein Disrupts Vesicle Fusion by Two Mutant-Specific Mechanisms
por: Yoo, Gyeongji, et al.
Publicado: (2022) -
Membrane Binding of α-Synuclein Stimulates Expansion of SNARE-Dependent Fusion Pore
por: Khounlo, Ryan, et al.
Publicado: (2021) -
Nonaggregated α-Synuclein Influences
SNARE-Dependent Vesicle Docking via Membrane Binding
por: Lai, Ying, et al.
Publicado: (2014) -
Early stages of aggregation of engineered α-synuclein monomers and oligomers in solution
por: Li, Xi, et al.
Publicado: (2019) -
Alpha-Synuclein Continues to Enhance SNARE-Dependent Vesicle Docking at Exorbitant Concentrations
por: Hawk, Brenden J. D., et al.
Publicado: (2019)